CAMP4 TherapeuticsCAMP
13F holders, Q2 2025 (June 30)29holders −10
7new positions
17sold out
1famous investor
$1.45avg. 13F price*
At the end of Q2 2025, 29 institutions reported holding CAMP4 Therapeutics Corp. (CAMP) in their 13F filings, down 10 from Q1 2025. 7 opened new positions and 17 sold out. The largest holders were Enavate Sciences Gp, LLC ($5.5M), 5AM Venture Management, LLC ($4.2M) and a16z Capital Management, L.L.C. ($3.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- CAMP4 Therapeutics Corp.
- CUSIP
- 13463J101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $296K |
| Exits | 17 | $2.9M |
All 13F filers, Q1 2025 → Q2 2025: 317,434 shares bought and 1,250,332 shares sold, net −932,898 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| Enavate Sciences Gp, LLC | 3.11% | No change | 3,785,802 | $5.5M |
| 5AM Venture Management, LLC | 1.63% | No change | 2,927,915 | $4.2M |
| a16z Capital Management, L.L.C. | 0.98% | No change | 2,125,339 | $3.1M |
| HarbourVest Partners LLC | 2.02% | No change | 1,271,948 | $1.8M |
| FMR LLC | 0.00% | Reduce -20.7% | 607,946 | $882K |
| Vanguard Group Inc. | 0.00% | Add +40.6% | 328,891 | $477K |
| Alyeska Investment Group, L.P. | 0.00% | No change | 200,000 | $290K |
| Millennium Management | 0.00% | New | 133,036 | $193K |
| BlackRock, Inc. | 0.00% | Reduce -71.6% | 84,221 | $122K |
| Victory Capital Management Inc. | 0.00% | Add +1.6% | 83,060 | $120K |
| Geode Capital Management, LLC | 0.00% | Reduce -52.9% | 75,199 | $109K |
| Goldman Sachs Group Inc. | 0.00% | Add +121.8% | 26,511 | $38K |
| Bridgeway Capital Management, LLC | 0.00% | New | 25,000 | $36K |
| Qube Research & Technologies Ltd | 0.00% | New | 14,871 | $22K |
| Verition Fund Management LLC | 0.00% | New | 14,760 | $21K |
| Northern Trust Corp. | 0.00% | Reduce -74.3% | 14,615 | $21K |
| Cantor Fitzgerald, L. P. | 0.00% | New | 12,320 | $18K |
| UBS Group AG | 0.00% | Add +59.9% | 5,088 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,830 | $6K |
| Morgan Stanley | 0.00% | Reduce -81.2% | 1,687 | $2K |
| Royal Bank of Canada | 0.00% | Add +126.9% | 953 | $2K |
| Bank of America Corp. | 0.00% | Reduce -80.0% | 652 | $946 |
| BNP Paribas Financial Markets | 0.00% | Add +101.4% | 427 | $619 |
| JPMorgan Chase & Co. | 0.00% | Reduce -97.1% | 238 | $345 |
| Wells Fargo & Company | 0.00% | Reduce -96.8% | 119 | $173 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -54.1% | 101 | $146 |
| SBI Securities Co., Ltd. | 0.00% | New | 20 | $29 |
| EverSource Wealth Advisors, LLC | 0.00% | Reduce -81.3% | 3 | $4 |
| Cwm, LLC | 0.00% | Reduce -73.8% | 68 | $0 |
"% of holder's portfolio" is CAMP's weight in each manager's 13F, not the share of CAMP4 Therapeutics Corp. the manager owns.